Skip to main content

Asuragen to Use NuGen's RNA Ovation Systems in Expression Analysis Service

NEW YORK (GenomeWeb News) – NuGen Technologies said today that Asuragen’s Pharmacogenomic Services Division will use NuGen’s RNA amplification and labeling products in its gene expression profiling services.
The company said Asuragen will use NuGen’s products for its services, which are performed on formalin-fixed paraffin-embedded tissue and whole blood samples on the Affymetrix GeneChip platform.
Asuragen will use the WT-Ovation FFPE Solution for global gene expression analysis of degraded RNA archives from FFPE samples using the Affy GeneChip Exon and Gene ST arrays, and the Ovation Whole Blood Solution for target preparation for gene expression analysis of samples as small as 20 ng of whole blood RNA.
Asuragen will include the NuGen products in its Encompass Services for FFPE portfolio, offered with analysis on Affy microarrays to give researchers access to information from archived samples.
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.